Antioxidant dietary supplement and related method
US-9517249-B2 · Dec 13, 2016 · US
US11147848B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11147848-B2 |
| Application number | US-201916299683-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 12, 2019 |
| Priority date | Sep 12, 2013 |
| Publication date | Oct 19, 2021 |
| Grant date | Oct 19, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to extracts, compounds isolated from Cakile arabica for use in the treatment of ulcer and to pharmaceutical compositions thereof.
Opening claim text (preview).
The invention claimed is: 1. A method for isolating tetracosanoic acid and 4-hydroxy-5-n-butoxy-5-oxopentanoic acid from Cakile arabica , the method comprising the steps: a. extracting a plant material of Cakile arabica to obtain an extract; b. concentrating the extract to obtain a concentrate; c. chromatographing the concentrate into fractions; and d. isolating fractionated compounds tetracosanoic acid and 4-hydroxy-5n-butoxy-5-oxopentanoic acid. 2. The method according to claim 1 , wherein the plant material comprises the aerial parts of Cakile arabica. 3. The method according to claim 1 , wherein extracting is carried out by using at least one organic solvent, selected from the group consisting of petroleum ether, heptane, hexane, ethanol, isopropanol, methanol and mixtures thereof, preferably is ethanol. 4. The method according to claim 1 , wherein chromatographing is carried out by means of thin layer chromatography (TLC) and/or column chromatography. 5. The method according to claim 4 , wherein said chromatographing is carried out with an eluent selected from the group consisting of petroleum ether, heptane, ethanol, methanol, benzene, diethyl ether, chloroform, dichloromethane, water and/or mixtures thereof. 6. The method according to claim 4 , wherein said chromatographing is carried out with a stationary phase selected from the group consisting of silica gel and aluminum oxide, or mixtures thereof.
involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones · CPC title
of acyclic acids, e.g. pravastatin · CPC title
by solid-liquid treatment; by chemisorption · CPC title
for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants · CPC title
Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.